Optimization of Positive End Expiratory Pressure by Use of Pulmonary Ultrasound for Patients With Blunt Chest Trauma Treated by Non-Invasive Ventilation (Opti-PEP).
Opti-PEP
1 other identifier
interventional
40
1 country
1
Brief Summary
This is an open-label, randomized controlled study comparing two non-invasive ventilation initiation strategies.Patients may be included if they present with acute respiratory failure related to blunt chest trauma.The intervention group will benefit from the use by the physiotherapist of pulmonary ultrasound for the adjustment of Positive End Expiratory Pressure (PEEP) during the 1st session. The conventional group will benefit from the non-invasive ventilation according to the current care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2023
CompletedFirst Posted
Study publicly available on registry
October 10, 2023
CompletedStudy Start
First participant enrolled
December 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 26, 2025
CompletedOctober 4, 2024
October 1, 2024
2 years
October 2, 2023
October 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PaO2/FiO2 ratio (Arterial oxygen pressure / inspired oxygen fraction) in both groups
PaO2/FiO2 ratio (Arterial oxygen pressure / inspired oxygen fraction) in both groups. This PaO2/FiO2 ratio is now the benchmark for qualifying the severity of the respiratory impairment or measuring the response to a mechanical ventilation strategy aimed at improving oxygenation.
at the 30th minute from the start of the 1st Non-invasive ventilation session
Secondary Outcomes (9)
Comparaison of the Lung Ultrasound Score (LUS) in both groups
at the 30th minute from the start of the 1st Non-invasive ventilation session
Comparaison of the PEEP value set at the start of the non-invasive ventilation session
At the start of the non-invasive ventilation session
Comparaison of the confort value in both groups
at the 30th minute from the start of the 1st Non-invasive ventilation session
Comparaison of the pain value in both groups
at the 30th minute from the start of the 1st Non-invasive ventilation session
Comparaison of the PaO2/FiO2 ratio in both groups
1 hour after the end of the 1st non-invasive ventilation session
- +4 more secondary outcomes
Study Arms (2)
Experimental
EXPERIMENTALThe intervention group will benefit from the physiotherapist's use of lung ultrasound for the PEEP adjustment during the first NIV session.
Control
ACTIVE COMPARATORThe conventional group will benefit from the NIV under the current terms.
Interventions
NIV is started and adjusted by the physiotherapist. For the adjustment of PEEP, the ultrasound probe is placed on the thorax, facing the intercostal space having obtained the highest score during the initial LUS (synonym of the worst pulmonary aeration) and the images observed in real time. PEEP is increased until the physiotherapist cannot see any additional benefit on pulmonary aeration or appearance of a patient discomfort or an increasing of air leaks.
The session will be done via a mouthpiece preferably, or a face mask if it is impossible for the patient to close their mouth properly or to hold the mouthpiece. The duration of the NIV session will be defined by the prescribing doctor (usually between 30 and 60 minutes), without being able to be less than 30 minutes. The session will be stopped in the event of the appearance of one of the contraindications to NIV mentioned above.
Arterial blood gas will be done at inclusion, at Visit 1 (at the 30th minute from the start of the 1st Non-invasive ventilation session) and at Visit 2 (at the 60th minute from the start of the 1st Non-invasive ventilation session) in both groups of patients in order to calculate the Pa02/Fi02 ratio.
The investigator physiotherapist interviews the participant to measure pain and comfort scores using a visual analogue scale (score from 0 to 10).
Eligibility Criteria
You may qualify if:
- Patients aged 18 or more
- Admitted to intensive care or continuing care for 72 hours or less for blunt chest trauma, defined by the presence of at least one of the following elements on the initial CT scan: fracture(s) of rib(s) / fracture(s) of the sternum / pulmonary contusion / hemothorax
- Acute hypoxemic respiratory failure defined by the administration of oxygen at least 3 L/min with nasal cannula or FiO2≥30% if high flow oxygen therapy.
- Patient with a functional arterial catheter for blood tests
You may not qualify if:
- Acute respiratory distress, defined by the presence of at least one of the following clinical signs: respiratory rate ˃ 35 / use of accessory inspirators / paradoxal abdominal or thoracic motion
- Imminent need for invasive mechanical ventilation
- Usual contraindication to non-invasive ventilation (undrained pneumothorax, trauma to the face, vigilance disorders, digestive bleeding, hemodynamic instability, intolerance)
- Hypercapnia (PaCO2˃45mmHg)
- Patient unable to cooperate, communicate
- Therapeutic limitation
- Expected length of stay ≤ 48h
- Severe head trauma
- Pregnant or breastfeeding women
- Participation in other clinical research related to respiratory failure/respiratory therapy
- Vulnerable people
- Protected adults, under guardianship or curatorship, or unable to give consent
- Non-affiliated person or beneficiary of a social security scheme
- Absence of free, informed and written consent, signed by the participant and the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UH of Montpellier
Montpellier, 34295, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2023
First Posted
October 10, 2023
Study Start
December 19, 2023
Primary Completion
December 19, 2025
Study Completion
December 26, 2025
Last Updated
October 4, 2024
Record last verified: 2024-10